Summarized by Masters of Longevity from Nature - Main.
A feature about a new gene‑tagging, epigenetic editing approach for silencing hepatitis B virus — what the article explains and why it matters.
Key Takeaways
- Epigenetic editing can silence hepatitis B viral genomes by adding chemical tags that prevent viral gene activity.
- Preclinical tests showed the treatment reduced viral particle production in human liver cells and in mice with limited side effects in monkeys.
- A clinical trial has begun to evaluate multiple intravenous doses in humans following promising preclinical efficacy and tolerability.
